UPDATE: Piper Sandler Upgrades Shockwave Medical (SWAV) to Overweight (correction)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/20/2024
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Jabil falls after placing CEO on paid leave amid internal investigation
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- NVIDIA (NVDA) Shares Extend Drop To 10%, Erasing $212 Billion In Value - Bloomberg
- Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
- Wells Fargo on Super Micro Computer (SMCI): 'No Positive Preannouncement
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Shockwave Medical (SWAV) PT Raised to $161 at Wells Fargo
May 11, 2021 6:59 AM EDTWells Fargo raised its price target on Shockwave Medical (NASDAQ: SWAV) to $161.00 (from $151.00) while maintaining a Overweight rating.... More
BofA Securities Upgrades Shockwave Medical (SWAV) to Buy After Issuing Triple Digit Growth Guidance
May 11, 2021 6:09 AM EDTBofA Securities upgraded Shockwave Medical (NASDAQ: SWAV) from Neutral to Buy with a price target of $180.00 after the company offered 2021 revenue guidance for the first time, which came in 20% above recently raised consensus expectations. This suggests SWAV will deliver 195% revenue growth in... More
Shockwave Medical (SWAV) PT Raised to $152 at Morgan Stanley
May 11, 2021 2:02 AM EDTMorgan Stanley analyst Cecilia Furlong raised the price target on Shockwave Medical (NASDAQ: SWAV) to $152.00 (from $145.00) while maintaining a Equalweight rating.... More
Shockwave Medical (SWAV) Misses Q1 EPS by 23c, Revenues Beat
May 10, 2021 4:22 PM EDTShockwave Medical (NASDAQ: SWAV) reported Q1 EPS of ($0.68), $0.23 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $31.9 million versus the consensus estimate of $29.9 million.
Recent Highlights
Recognized revenue of $31.9 million for the first quarter of 2021, representing an increase of 110% from the same period in 2020Received Pre-Market Approval... More
